Yang Shuai, Li Mengqiu, Lian Guangyu, Wu Yaoxing, Cui Jun, Wang Liqiu
MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences of Sun Yat-sen university, Guangzhou, Guangdong, China.
Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Autophagy. 2025 Feb;21(2):338-351. doi: 10.1080/15548627.2024.2395158. Epub 2024 Sep 3.
The NLRP3 inflammasome is a multiprotein complex that plays a vital role in the innate immune system in response to microbial infections and endogenous danger signals. Aberrant activation of the NLRP3 inflammasome is implicated in a spectrum of inflammatory and autoimmune diseases, emphasizing the necessity for precise regulation of the NLRP3 inflammasome to maintain immune homeostasis. The protein level of NLRP3 is a limiting step for inflammasome activation, which must be tightly controlled to avoid detrimental consequences. Here, we demonstrate that ABHD8, a member of the α/β-hydrolase domain-containing (ABHD) family, interacts with NLRP3 and promotes its degradation through the chaperone-mediated autophagy (CMA) pathway. ABHD8 acts as a scaffold to recruit palmitoyltransferase ZDHHC12 to NLRP3 for its palmitoylation as well as subsequent CMA-mediated degradation. Notably, deficiency results in the stabilization of NLRP3 protein and promotes NLRP3 inflammasome activation. We further confirm that ABHD8 overexpression ameliorates LPS- or alum-triggered NLRP3 inflammasome activation . Interestingly, the nucleocapsid (N) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impairs the ABHD8-NLRP3 association, resulting in an elevation in NLRP3 protein level and excessive inflammasome activation. These findings demonstrate that ABHD8 May represent a potential therapeutic target in conditions associated with NLRP3 inflammasome dysregulation. 3-MA: 3-methyladenine; ABHD: α/β-hydrolase domain-containing; BMDMs: Bone marrow-derived macrophages; CFZ: carfilzomib; CHX: cycloheximide; CMA: chaperone-mediated autophagy; CQ: chloroquine; DAMPs: danger/damage-associated molecular patterns; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; LAMP2A: lysosomal associated membrane protein 2A; NHCl: ammonium chloride; NLRP3: NLR family pyrin domain containing 3; PAMPs: pathogen-associated molecular patterns; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.
NLRP3炎性小体是一种多蛋白复合物,在先天性免疫系统中对微生物感染和内源性危险信号的应答中发挥着至关重要的作用。NLRP3炎性小体的异常激活与一系列炎症和自身免疫性疾病有关,这凸显了精确调控NLRP3炎性小体以维持免疫稳态的必要性。NLRP3的蛋白水平是炎性小体激活的一个限制步骤,必须对其进行严格控制以避免产生有害后果。在此,我们证明了含α/β水解酶结构域(ABHD)家族成员ABHD8与NLRP3相互作用,并通过伴侣介导的自噬(CMA)途径促进其降解。ABHD8作为一个支架,招募棕榈酰转移酶ZDHHC12至NLRP3,使其发生棕榈酰化以及随后的CMA介导的降解。值得注意的是,ABHD8缺陷导致NLRP3蛋白稳定并促进NLRP3炎性小体激活。我们进一步证实,ABHD8过表达可改善脂多糖或明矾触发的NLRP3炎性小体激活。有趣的是,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的核衣壳(N)蛋白损害ABHD8与NLRP3的结合,导致NLRP3蛋白水平升高和炎性小体过度激活。这些发现表明,ABHD8可能是与NLRP3炎性小体失调相关病症的一个潜在治疗靶点。3-MA:3-甲基腺嘌呤;ABHD:含α/β水解酶结构域;BMDM:骨髓来源的巨噬细胞;CFZ:卡非佐米;CHX:放线菌酮;CMA:伴侣介导的自噬;CQ:氯喹;DAMP:危险/损伤相关分子模式;HSPA8/HSC70:热休克蛋白家族A(Hsp70)成员8;LAMP2A:溶酶体相关膜蛋白2A;NHCl:氯化铵;NLRP3:含NLR家族pyrin结构域3;PAMP:病原体相关分子模式;SARS-CoV-2:严重急性呼吸综合征冠状病毒2